Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1103006ffcd56064272908e670699315 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 |
filingDate |
2018-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04a0b060e1b7d6b4c1af73415a22d841 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd4e87f2667ebd5a5c22af468570d7bd |
publicationDate |
2020-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-111278811-A |
titleOfInvention |
Aminobenzimidazole derivatives, methods of treating and inhibiting histone deacetylases |
abstract |
The present invention relates to novel aminobenzimidazole derivatives. The present invention also relates to methods of treating diseases associated with histone deacetylase (HDAC) or inhibiting the histone deacetylation activity of HDAC isoforms in a cell with one or more aminobenzimidazole derivatives. |
priorityDate |
2017-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |